What does this research mean for the field?

Proinflammatory adipokines are key mediators of insulin resistance and systemic inflammation in visceral obesity, and normalizing their levels offers additional clinical benefits in preventing and treating obesity-related type 2 diabetes and cardiovascular disease. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

December 7, 2009Current Drug Targets

Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?

View Full Paper

Ask AI

Bookmark

Authors

VAVasilios G. AthyrosPreventive Cardiology ΚΤΚωνσταντίνος ΤζιόμαλοςGeneral / Preventive / Lipids AKAsterios KaragiannisGeneral / Preventive / Lipids

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Athyros et al. (2009) studied this question.

synapsesocial.com/papers/6a0932e41d1abd907d16119b https://doi.org/10.2174/138945010790030992

View Full Paper

Ask AI

Bookmark

December 7, 2009Current Drug Targets

Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?

View Full Paper

Ask AI

Bookmark

Authors

VAVasilios G. AthyrosPreventive Cardiology ΚΤΚωνσταντίνος ΤζιόμαλοςGeneral / Preventive / Lipids AKAsterios KaragiannisGeneral / Preventive / Lipids

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Athyros et al. (2009) studied this question.

synapsesocial.com/papers/6a0932e41d1abd907d16119b https://doi.org/10.2174/138945010790030992

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark